Relationships between 80 Human Papillomavirus Genotypes and Different Grades of Cervical Intraepithelial Neoplasia: Association and Causality  by Matsukura, Toshihiko & Sugase, Motoyasu
tVirology 283, 139–147 (2001)
doi:10.1006/viro.2001.0865, available online at http://www.idealibrary.com onRelationships between 80 Human Papillomavirus Genotypes and Different Grades
of Cervical Intraepithelial Neoplasia: Association and Causality
Toshihiko Matsukura*,1 and Motoyasu Sugase†
*Laboratory of Tumor Viruses, Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640; and †Department of Obstetrics
and Gynecology, Nagano Red Cross Hospital, Nagano 380-8582, Japan
Received November 30, 2000; returned to author for revision January 5, 2001; accepted February 9, 2001
To clarify the causal relationship between human papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN), we
analyzed 386 unfixed biopsy specimens by blot hybridization at Tm 240°C, targeting 38 skin and 42 genital HPVs. By the
recognition of PstI, BanI, and MspI cleavage patterns, single genital, but no skin’s HPVs were identified with more than 10
copies per cell in 354 CIN (88 CIN I, 94 CIN II, and 172 CIN III). HPVs 40, 42, 43, 54, 62, or 71 was found in 10 CIN I, while
HPVs 18, 30, 39, 51, 56, 59, 66, 68, 69, or 82 was found in 35 CIN I, 20 CIN II, or 8 CIN III. On the other hand, HPVs 16, 31,
33, 35, 52, 58, or 67 was identified in 43 CIN I, 74 CIN II, or 164 CIN III. The results are strongly indicative that most genital
HPVs have potency to induce CIN I; however, HPV 16 and its closely related types are able to efficiently induce CIN III. We
discuss the definition of causal HPV for CIN with regard to viral prevalence and viral load. © 2001 Academic Press
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A causal relationship between an infectious agent and
a specific disease is rather easy to establish when an
agent is rare and a disease is acute. Human papilloma-
viruses (HPVs), however, are ubiquitous and their asso-
ciated diseases are latent. Now, more than 80 HPV
genotypes are established, of which HPVs associated
with genital lesions are classified as genital HPV, differ-
ent from skin HPV associated with skin lesions. Genital
HPV DNA has been consistently detected in invasive
cervical carcinoma (ICC) and its precursor, cervical in-
traepithelial neoplasia (CIN). The overwhelming epide-
miological studies fulfill the postulates of a causal agent
proposed before (Rivers, 1937; Hill, 1965; Evans, 1976),
and the association is considered causal (zur Hauzen,
1995; Mun˜oz and Bosh, 1996).
However, our understanding with pathological behav-
iors of individual genital HPV types is still not clear. Some
genital HPVs are categorized as high-risk type, fre-
quently associated with ICC, different from the low-risk
type associated with benign lesions. Yet, HPVs desig-
nated as high-risk type are different from study to study
(Bosch et al., 1995; Brown et al., 1999; Herrero et al.,
2000; Jacobs et al., 2000; Kino et al., 2000; Liaw et al.,
1999; Nindl et al., 1999b; Olsen et al., 1995). Moreover,
there is a marked discrepancy of HPV associated with
CIN, which is graded from I to III depending on the
1 To whom reprint requests should be addressed. E-mail:
oshi@nih.go.jp. Fax: 181 3 5285 1161.
139degree of epithelial abnormality. In a critical review, it
was summarized that HPVs 6 and 11 have been found in
less than 30% of CIN I and that HPV 16 has been de-
tected in over 50% of CIN II and III, followed by HPVs 31,
33, 35, 39, 45, and 56. CIN I, but not CIN II and III, is
frequently associated with more than one HPV (Wright
and Kurman, 1996). In another review simultaneously
published, it was summarized that HPVs 16 and 18 were
the most commonly detected types in CIN II and III in all
epidemiological studies, but a few lesions contained
HPVs 6 and 11 (Mun˜oz and Bosch, 1996). In addition,
some skin HPVs were associated with CIN (Lungu et al.,
1992; Ferrera et al., 1999). If the association were causal,
any HPV could occasionally induce CIN by chance. On
the contrary, it is possible that HPV is not causal but
lingers in CIN much longer than in normal epithelium
(Ponte´n et al., 1995).
In the present study, we analyzed fresh unfixed biopsy
specimens of CIN by blot hybridization at Tm 240°C
using various HPVs as probes, to assess the causal
relationships between all skin and genital HPVs and
different grades of CIN. We discuss the definition of
causal HPV for CIN, with regard to viral prevalence and
viral load.
RESULTS
Detection and identification method for HPV in CIN
For identification of HPV in CIN, we used the blot
hybridization method at Tm 240°C, based on the recog-
nition of PstI, BanI, and MspI cleavage patterns of HPV
(Matsukura and Sugase, 1995). Accordingly, we first an-
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140 MATSUKURA AND SUGASEalyzed the cleavage patterns of 80 HPV prototypes, 42
genital and 38 skin HPVs, using the nucleotide se-
quences in the databases (see Materials and Methods).
Because HPVs 43, 62, 64, 68, 74, and 81 were not com-
pletely sequenced, their cleavage patterns were deter-
mined by analysis of our clinical specimens. It revealed
that almost all genital and skin HPVs might be distin-
guishable by the three cleavage patterns (data not
shown, see PstI-A to -D fragments of 42 genital HPVs in
Table 1). However, each HPVs 44 and 55 and HPVs 34
and 64 exhibit nearly identical cleavage patterns with the
three enzymes. Each set of two HPVs shares more than
90% similarity with the nucleotide sequence of the L1
ORF and was considered as the same HPV as previously
indicated (Chan et al., 1995).
Subsequently, to know whether or not all genital HPVs
might be identified by the blot hybridization at Tm 240°C
ith the HPV 58 probe (PBM-58), we examined more than
580 clinical specimens and could identify 39 of 42 genital
PVs, except for HPVs 13, 26, and 32. For example, as
hown in Fig. 1, specimens 1000, 1034, 1065, 1197, and 1680
ere clarified to harbor recently cloned HPVs 73, 83, 81, 74,
nd 82, respectively, by the characteristic PstI (P), BanI (B),
r MspI (M) cleavage patterns of their respective prototypes
see Table 1). Representative results of PstI cleavage pat-
erns of genital HPVs are shown in Fig. 2. HPVs 13, 26, 32,
0, 45, 70, 72, and 73 were not examined. Most HPVs
xhibited the identical patterns of their respective proto-
ypes. It was assumed that the sequence of HPV might be
xtremely conserved and that PBM-58 would be a reliable
ethod to detect and identify all genital HPVs in CIN. It was
ot known, however, whether the amount of HPV DNA in
IN was sufficient enough to be detectable by the HPV 58
robe. Moreover, the HPV 58 probe might selectively detect
ne HPV type among multiple HPVs present in a single
IN. Consequently, 33 different genital HPVs, HPVs 6, 11,
T
PstI Cleavage Patterns of 42
HPV 6 7 11 13 16 18 26 30 31 3
PstI-A 3692 3334 1774 2162 2818 6337 2956 5706 2832 49
B 1741 2513 1594 1944 1776 555 2708 2146 1627 14
C 1496 917 1503 1522 1549 457 966 1552 8
D 1081 838 1042 1205 1064 441 872 1112 4
HPV 53 54 55 56 58 59 61 62* 64* 6
PstI-A 3856 2418 2335 7409 4544 3891 5742 2.5 3.0 71
B 2061 2176 1837 333 1726 3862 2107 1.8 2.0 4
C 1467 2049 1837 102 918 143 140 1.5 1.2 1
D 433 676 921 300 1.4 0.5
Note. The sizes of PstI-A to -D fragments of completely sequenced H
(see text).3, 16, 18, 26, 30, 31, 33, 35, 39, 40, 42, 43, 45, 51, 52, 53, 54,
5, 56, 59, 61, 62, 64, 66, 67, 68, 69, 71, 73, 81, and 82, weresed as probes. Concerning 38 skin HPVs, HPVs 1, 2, 3, 4,
, 8, 9, 10, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29,
6, 37, 38, 41, 47, 48, 49, 57, 60, 63, 65, 75, 76, 77, 78, and 80,
skin HPVs, HPVs 5, 20, 28, 36, 41, 57, 60, and 65 were used
s probes under the same analytical conditions. Using the
al Human Papillomaviruses
3 34 35 39 40 42 43* 44 45 51 52
05 3044 3403 3317 3241 2571 2.2 2335 5426 2908 2765
11 2012 1796 1270 2098 1767 1.9 1834 2432 2434 2239
73 1248 1687 1049 1215 1174 1.9 1659 1325 928
20 508 546 951 838 1167 1.0 1084 1141 906
7 68* 69 70 71 72 73 74* 81* 82 83
21 3.3 2755 4562 2880 3825 5199 6.9 4.4 3892 2713
44 2.3 2585 1240 1125 2693 1985 1.0 2.2 3621 1417
31 1.0 1297 951 1079 2010 516 0.9 358 1115
0.7 701 733 908 928
e indicated in bp. The sizes of HPVs with asterisks are indicated in kb
FIG. 1. Blot hybridization analysis of HPV sequences in clinical
specimens. Total DNA from biopsy specimens was digested with PstI
(P), BanI (B), or MspI (M) and electrophoresed on 1% agarose gels. After
transfer to nitrocellulose filters, DNA was hybridized with the HPV 58
DNA probe at Tm 240°C. Numerals above the lanes represent theABLE 1
Genit
2 3
22 46
83 20
51 11
05 1
6 6
73 49
35 23
50 5
66specimen numbers. The size of the PstI-A fragment was indicated in bp
or kb (see Table 1).
. The s
141HPV IN CINprobes, we could identify 20 skin HPVs in our clinical
specimens. On the other hand, the sensitivity of blot hybrid-
ization was estimated by reconstitution experiments with
HPV clone DNA, and it was assumed that a 0.05 copy of an
entire HPV molecule per diploid cell could be detected in
the blot hybridization system, using at best 5 mg total DNA
from biopsy specimen (data not shown).
Genital, but no skin, HPVs were identified in most CIN
By the HPV detection system, we analyzed 386 cases
of CIN, consisting of 98 CIN I, 100 CIN II, and 188 CIN III.
As summarized in Table 2, no skin HPV was found in any
TABLE 2
Skin and Genital HPVs in Different Grades of CIN
HPV
CIN I
(n 5 98)
CIN II
(n 5 100)
CIN III
(n 5 188)
Total
(n 5 386)
Skin HPV 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Genital HPV 88 (90%) 94 (94%) 172 (91%) 354 (92%)
Unidentified HPV 1 (1%) 2 (2%) 5 (3%) 8 (2%)
Multiple HPVs 0 (0%) 2 (2%) 2 (1%) 4 (1%)
FIG. 2. PstI cleavage patterns of genital HPVs. Total DNA from clinica
After transferred to nitrocellulose filters, DNA was hybridized with the
types. No sample was analyzed in lanes 13, 26, 32, 40, 45, 70, 72, and 73
in bp (see Table 1).Negative 9 (9%) 2 (2%) 9 (5%) 15 (5%)CIN. On the other hand, single genital HPVs were found
in 354 CIN, while unidentified HPVs were found in 8 CIN.
In addition, 4 CIN harbored two different HPVs: 2 CIN II
with HPV 16 and an unidentified type and HPVs 42 and
59; 2 CIN III with HPV 58 and an unidentified type, and
HPV 82 and an unidentified type. The remaining 15 cases
of CIN were negative for HPV. The frequency of HPV
detection was nearly similar among different grades of
CIN. In addition, more than 10 viral genome copies per
cell were present in every CIN, and the viral load was not
significantly different in different grades of CIN for any
HPV. Since almost all HPVs exhibited enzyme cleavage
patterns identical to those of their respective prototypes,
HPV DNA might safely replicate in CIN without major
deletions or rearrangements, although its physical state,
such as episomal or integrated form was not known.
HPV type-specific distribution in different grades
of CIN
Finally, we compared HPV type-specific distribution
in different grades of CIN. In Fig. 3, genital HPVs
identified in CIN were arranged according to the
ens was digested with PstI and electrophoresed on 1% agarose gels.
DNA probe at Tm 240°C. Numerals above the lanes represent HPV
ize of the PstI-A fragment of completely sequenced HPV was indicatedl specim
HPV 58groups in Table 3. A single open, double open, and
single closed circle represents one case of CIN I, II, or
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142 MATSUKURA AND SUGASEIII, respectively. CIN associated with multiple or un-
identified HPVs was excluded. At a glance, there are
three clear trends emerging. First, groups A1, A3, and
A10 and HPVs 54 and 71 were found in a few cases of
CIN I. Second, groups A5 to A7 were found in CIN I
and II, but rarely in CIN III. Third, group A9 was
dominantly found in CIN III, where HPV 16 was pre-
dominant, followed by HPVs 58, 52, and 31. The dis-
tinguishable detection frequencies in different grades
of CIN were evident among different HPV groups,
suggesting strongly the correlation between nucleo-
FIG. 3. Genital HPVs in different grades of CIN. Genital HPVs identi
ccording to the groups in Table 3. Each single open, double open, atide sequences of viral genome and potency to induce
CIN.
H
mDISCUSSION
Association is not sufficient for causality
In epidemiological studies, the geographic variation in
the prevalence of genital HPV was often noted (Ferrera et
al., 1999; Herrero et al., 2000; Jacobs et al., 2000; Lorincz et
l., 1992; Nindl et al., 1999b); however, we wondered if
pecific HPVs might be prevalent within different geo-
raphic regions. Since 22 genital HPVs were found in vag-
nal intraepithelial neoplasia (VAIN) of 71 women at a hos-
ital in Japan (Sugase and Matsukura, 1997), 22 genital
354 cases of CIN (88 CIN I, 94 CIN II, and 172 CIN III) were arranged
le closed circle represents one case of CIN I, II, and III, respectively.PVs were found in normal penile brush samples of 147
en at a hospital in Sweden (Wikstro¨m et al., 2000), and
143HPV IN CINmore than 30 genital HPVs were found in cervical smears
of 608 students at a university in the U.S.A. (Ho et al., 1998a),
most genital HPVs must be present even in a very restricted
area the world over. On the other hand, the prevalence
rates of genital HPVs have been studied with cervical
smears of women without CIN in different geographic lo-
cations. In the United States, 28 of 28 genital HPVs were
present in 0.2 to 2.4% of 500 women (Palefsky et al., 1999),
while 23 of 32 genital HPVs and one skin HPV were present
in 0.1 to 0.9% of 3305 women in the Netherlands (Jacobs et
al., 2000). In addition, 22 of 35 genital HPVs were found in
0.3 to 2.0% of 305 women in Costa Rica (Herrero et al.,
2000). Since different PCR systems were used for targeting
different HPVs in these studies and different PCR systems
have differing sensitivities and characteristics for the de-
tection of HPV (Nindl et al., 1999a; Qu et al., 1997; Smits et
al., 1995; Ylitalo et al., 1995), and, furthermore, since some of
the tested women might have had VAIN (Sugase ant Mat-
sukura, 1997), there may be no large geographic variation in
the prevalence of all genital HPVs among women harboring
neither CIN nor VAIN worldwide.
However, little is know about the reservoir of genital
HPV. Because various genital or skin HPVs were found in
normal oral smears (Terai et al., 1999), normal penile
brush specimens (Wilkstro¨m et al., 2000), and pubic,
preanal, or eyebrow hairs (Boxman et al., 1999), HPV may
replicate in squamous epithelial cells of people and
readily spread from person to person by means of ordi-
nary household and community contacts, although it is
mainly transmitted to the female genital tract via sexual
contact (Andersson-Ellstro¨m et al., 1994; Gutman et al.,
1993; Ingram et al., 1992).
CIN only occurs in a small minority of women who are
infected with such heterogeneous and ubiquitous HPVs.
To know the causality of HPV for CIN, cervicovaginal
smears of women with CIN have been extensively ex-
amined by PCR. However, smears contain exfoliated
cells from lesional and normal cervical epithelium, as
well as vaginal epithelium, and there is no guarantee that
HPV detected in smears is necessarily associated with
CIN. In addition, any PCR system likely does not meet all
conditions for success for detection of all HPVs in
smears (Nindl et al., 1999a; Qu et al., 1997); moreover,
there is no way to estimate the accurate amount of HPV
detected by PCR in smear (Tucker et al., 1993). Thus, we
consider that it is difficult to establish the causality of
HPV for CIN using smear specimens and PCR.
Causality and viral load
Consequently, we examined unfixed biopsy speci-
mens of CIN by PBM-58, which is extremely less sensi-
tive than PCR, and found only 4 of 386 CIN associated
with multiple HPVs (Table 2). In fact, when total DNA from
CIN was analyzed by PCR, partial nucleotide sequences
of multiple HPVs were found in some specimens (datanot shown). As with PCR, a positive test result by PBM-58
does not necessarily mean absence of the other HPVs in
CIN. However, all the HPVs that were detected only by
PCR could not be detected by the blot hybridization using
corresponding HPV probes. The amount of HPV detect-
able only by PCR must be less than 0.05 copies per cell.
On the other hand, with PBM-58 we fortunately found
single HPV in most CIN with more than 10 genome
copies per cell (106 molecules in 1 mg total DNA) and no
HPV in 46 histopathologically normal cervical tissues
examined. As biopsy tissues contain cells from normal
epithelium and underlying stroma, the viral copy number
must be higher than 10 in the lesional epithelium. In
addition, although the number was limited, we examined
the sections of formalin-fixed, paraffin-embedded tissues
of CIN associated with multiple HPVs by in situ hybrid-
ization and could confirm the histological distribution of
the HPV detected by PBM-58 but not that of the HPV
detected only by PCR (Kino et al., 2000). We, therefore,
presume at present that HPV detected by PBM-58 is
causal for CIN, regardless of possible concomitant HPVs
detectable only by PCR. The definition is, at least, de-
pendent on two conditions that HPVs detectable only by
PCR play no role in CIN and that HPV detected by
PBM-58 is demonstrated in the lesional epithelium by in
situ hybridization.
Causal HPV for CIN
Only 23 of 42 genital HPVs were found in CIN (Fig. 3);
however, almost all genital HPVs may be prevalent with
subtle differences in our study population, because 39
genital HPVs were identified in VAIN or other lesions
(unpublished data; Sugase and Matsukura, 1997). Be-
cause of the limitations of a convenience sample (see
Materials and Methods), we could not systematically
ensure equal probability of representing all CIN; how-
ever, the detection frequencies of HPVs in CIN may
highly reflect the potencies of individual HPVs to induce
different grades of CIN. CIN exhibits the complex natural
course, such as regress, persist, or progress, and does
not necessarily develop in a stepwise fashion through
increasing grades of CIN (Wright and Kurman, 1996). For
simplicity, the data may be interpreted as follows: Groups
A1, A3, A8, A10, and A11 and HPVs 54 and 71 induce CIN
I, which spontaneously regresses, while groups A5 to A7
induce CIN I, which progresses to CIN II but rarely to CIN
III. On the other hand, group A9 induces CIN I, which
progresses to CIN II or III. Only HPV lingered in CIN
much longer than in normal epithelium, the distribution of
HPV in CIN would be more heterogeneous, since any
HPVs may have a chance to infect CIN during or after its
development. The distinguishable detection frequencies
among different HPV groups themselves might be sup-
porting evidence for the idea that HPV is a sole causal
agent for CIN.
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144 MATSUKURA AND SUGASEIf so, even geographically remote populations will
show the same constellation of HPVs in CIN. However,
there are a few reports concerning biopsy specimens
and Southern blot hybridization. In a report from the
U.S.A., HPVs 16, 31, and 18 of 15 genital HPVs were
dominantly found in 123, 27, and 13 cases of 261 CIN
II or III, respectively (Lorincz et al., 1992). In another
report from France, HPV 16 of 18 HPVs was predomi-
nantly found in 38 of 53 CIN II or III (Bergeron et al.,
992). Because HPV typing in these two reports was
ased only on the recognition of PstI cleavage pat-
erns, the results cannot be synthesized with our data,
s previously discussed (Matsukura and Sugase,
995). Among overwhelming studies concerning
mear specimens and PCR, HPVs 16, 31, and 33 of 14
PVs were dominant both in 31 CIN II and in 34 CIN III
n Germany (Nindl et al., 1999b), while HPVs 16, 52,
nd 58 of 29 HPVs were dominant both in 51 CIN II and
n 44 CIN III in the U.S.A. (Ho et al., 1998b), and HPVs
6, 58, 51, and 52 of 35 HPVs were dominant in 125 CIN
I or III in Costa Rica (Herrero et al., 2000). The latter
wo results somewhat resemble our data. If any HPV
ight exceptionally induce CIN III in different geo-
raphic locations, it would be impossible to specify
he causal HPVs for CIN III throughout the world.
Incidentally, a cohort study revealed that each HPV 16
nd HPV 18 infection was a high-risk factor for CIN II and
II (Koutsky et al., 1992). In a large nested case-control
tudy, however, only HPV 16 infection predicted an ele-
ated risk of CIN II and III (Liaw et al., 1999). Thus, our
nderstanding of the pathological behaviors of 42 genital
PVs is extremely limited. Astonishingly enough, how-
ver, it was noted in a study of HPV infection with 1778
uman immunodeficiency virus-positive women that HPV
8, together with HPVs 6, 11, 40, 45, 51, 53, 54, 55, 56, 59,
nd 68 of 29 genital HPVs, was significantly more com-
on among the women in the lower CD4 strata (Palefsky
t al., 1999). All the HPVs belong to groups other than
roup A9. This is highly suggestive that the HPVs are
ess aggressive toward immunocompetent women, con-
istent with our results in Fig. 3.
Needless to say, because of the small number of CIN,
ur results must be weighted for evaluation with analysis
f larger cases of CIN from various geographic areas
argeting all HPVs. We hope that the present study may
hed some light as an introduction of a proper HPV
etection system for clinical management (Kaufman and
dam, 1999; Koss, 2000).
PV genes and CIN
At the beginning of this study, we classified 80 HPVs
nto 42 genital and 38 skin HPVs, founded on the previ-
usly established L1 phylogenetic tree (Chan et al.,
995). However, we did not totally accept the phyloge-
etic genital groups (supergroup As), because the phy-ogenetic trees deduced for the L1 ORF do not link HPVs
n the same way as the trees deduced for the E6 ORF
Rho et al., 1994; Van Ranst et al., 1992; Kirii and Mat-
ukura, 1998; see also Table 3) and the deduction of any
hylogenetic relationships could not be made for the
hole virus. We selected 40 HPVs from the supergroup
s, and HPVs 53 and 71 as genital HPV (Table 3), while
HPVs in supergroups A2 (HPVs 3, 10, 28, 29, and 77)
nd A4 (HPVs 2, 27, and 57), and the remaining 30 HPVs
s skin HPV exhibiting distinct histopathological
hanges in skin lesions (Jablonska et al., 1985). In fact,
roups A2 and A4 have more closely related E6 and L1
RFs to HPV16 than group A3 (data not shown) and
eem to be able to induce CIN or VAIN. However, they, as
ell as the other skin HPVs, were not found in any CIN
r VAIN (Sugase and Matsukura, 1997). It is noteworthy
hat all skin HPVs, with the exception of HPVs 1, 5, and 41,
o not have the E5 ORF; in comparison, all genital HPVs
ave it. We speculate that the E5 gene may be indis-
ensable for inducing CIN or VAIN. On the other hand, in
pite of genital HPV, HPVs 6 and 11 were not found in 386
IN, as previously published in a study with 101 CIN
Bergeron et al., 1992). We wonder whether HPVs 6 and
1 could induce CIN, even the so-called flat condyloma.
n our series, only HPV 6 was identified in 54, 17, and 14
ases and HPV 11 in 22, 6, and 9 cases of vulval, vaginal,
nd cervical exophytic condyloma acuminatum, respec-
ively (unpublished data; Sugase et al., 1991; Matsukura
nd Sugase, 1995; Sugase and Matsukura, 1997). Since
nly the HPVs in group A10 share an identical second
RF (E5b) downstream of the E5 ORF, the E5b gene may
lay important roles for condyloma acuminatum on the
ulva, the vagina, and the cervix.
Incidentally, the detection frequencies of the other
enital HPVs in CIN likely are correlated with their sim-
larities to the E6 ORF of HPV 16 (Fig. 3 and Table 3).
owever, HPVs in group A11, which have a closely re-
ated E6 gene, as well as E7 gene, to that of HPV 16,
ere not found in any CIN. This highly suggests that the
otency to induce CIN may be controlled by various viral
enes. It was reported that the risk for CIN II or III was
ependent on the sequence variation of no coding re-
ion of HPV 16 (Xi et al., 1997). For parsing the confusing
omplexity of CIN, however, it will be necessary to clarify
he causal relationships between HPVs and different
rades of CIN. Further insights into the molecular mech-
nisms of CIN might be provided by research on the
iological activities of every gene of genital and skin
PVs, as well as those of animal papillomaviruses
Ustav and Stenlund, 1991).
In conclusion, we tentatively propose four categories
f 80 HPVs for CIN as follows:
(1) HPVs 6 and 11 and 38 skin HPVs (induce no CIN).
(2) 17 HPVs in groups A1, A3, A8, A10, and A11, and
HPVs 54 and 71 (induce exclusively CIN I).
t145HPV IN CIN(3) 14 HPVs in groups A5 to A7 (induce CIN I and II,
but rarely CIN III).
(4) 7 HPVs in group A9 (induce CIN I and II, as well as
CIN III).
The epidemiological studies of genital HPV fulfill the
postulates of a causal agent proposed before and pro-
TABLE 3
The 42 Genital Human Papillomavirus Types
Supergroup HPV type (GC%)
Similarity with
HPV 16a
(Accession No.)E6 ORF L1 ORF
A3 61 (46) 39 63 (U31793)
83 (46) 41 61 (AF151983)
72 (46) 38 64 (X94164)
81 65 (U12480)
62 65 (U12499)
b 71 (44) 36 57 (AB040456)
A8 40 (44) 38 68 (X74478)
7 (40) 38 69 (X74463)
43 72 (U12504)
b 54 (42) 42 71 (U37488)
A10 44 (41) 40 67 (U31788)
11 (41) 37 68 (M14119)
55 (41) 37 67 (U31791)
6 (41) 39 68 (L41216)
13 (39) 37 68 (X62843)
74 67 (U40822)
A1 32 (41) 42 72 (X74475)
42 (40) 42 70 (M73236)
A7 18 (40) 57 64 (X05015)
70 (40) 58 62 (U21941)
39 (40) 56 64 (M62849)
45 (40) 57 64 (M74479)
59 (39) 52 65 (X77858)
68 62 (X67161)
A6 30 (40) 53 65 (X74474)
53 (40) 52 64 (X74482)
66 (38) 50 65 (U31794)
56 (38) 56 64 (X74483)
A5 82 (40) 57 63 (AB027021)
51 (39) 58 64 (M62877)
69 (39) 54 64 (AB027020)
26 (39) 55 66 (X74472)
A11 34 (38) 61 70 (X74476)
73 (36) 62 71 (X94165)
64 72 (U12495)
A9 52 (39) 64 76 (X74481)
67 (38) 57 75 (D21208)
58 (38) 64 76 (D90400)
31 (37) 66 81 (J04353)
35 (37) 72 83 (X74477)
33 (37) 64 78 (M12732)
16 (37) 100 100 (K02718)
a % similarity of amino acid sequences of the E6 and the L1 ORF with
hose of HPV 16.
b HPVs 54 and 71 are not phylogenetically grouped.vide the concept that the association is tantamount to the
causality. However, something in addition to the avail-able postulates should be used to establish the causality
of HPV. This could be knowledge of the viral type, the
length of the viral genome, and the amount of viral DNA
in the lesions.
MATERIALS AND METHODS
Biopsy specimens and histological examination
From 1992 through 1999, this study was conducted at
the out-patient clinic of the Nagano Red Cross Hospital
in Nagano city, with a population of about 500,000 inhab-
itants. All the patients were Japanese and immunocom-
petent. Under careful colposcopic examination with ap-
plication of 5% acetic acid, punch biopsies were taken
from cervical lesions and divided into two parts, of which
one was fixed in 10% buffered formalin for routine histo-
pathology and the other was stored in a 1.5-ml polypro-
pylene tube at 280°C until HPV analysis. By histopatho-
logic examination, CIN was graded in three categories,
CIN I, II, and III, according to the highest grade present
within a lesion. CIN III included carcinoma in situ and
CIN I included so-called flat condyloma, namely flat
aceto-white lesions showing marked koilocytotic change
with scarce nuclear atypia, different from florid exophytic
condyloma acuminatum. During the 8 years, we ob-
served 534 cases of CIN and collected, with no time
period bias, 386 CIN [98/158 (62%) CIN I, 100/146 (68%)
CIN II, and 188/230 (82%) CIN III], including 196 cases of
CIN (59 CIN I, 48 CIN II, and 89 CIN III) reported previ-
ously (Matsukura and Sugase, 1995).
HPV clones and sequence analysis
HPVs 6, 11, 13, 16, 18, 40, 41, 45, 53, and 73, HPVs 32,
33, 39, 54, 55, and 66, and HPV 26 were kindly provided
by Dr. E.-M. de Villiers, Drs. M. Favre and G. Orth, and Dr.
Ostrow, respectively. HPVs 35 and 44 were purchased
from the ATCC (Rockville, MD). The other HPV clones
used in the present study were isolated in our laboratory.
In addition, we found a novel HPV DNA with character-
istic PstI, BanI, and MspI cleavage patterns in VAIN I (see
specimen 1065 in Fig. 1) and cloned it within the XbaI site
of plasmid Bluescript. Dr. Delius determined its L1 se-
quence by primer-directed sequencing (Delius and Hof-
mann, 1994) and designated it as HPV 81 (Drs. Delius
and de Villiers, International Reference Center of HPV,
Heidelberg, Germany). Additionally we determined the
entire nucleotide sequence of HPV 71 cloned originally
by us (Sugase and Matsukura, 1997) and submitted it to
the databases under accession No. AB040456.
Incorporating HPV 81 and HPVs 82 and 83, which were
recently established (Brown et al., 1999; Kino et al., 2000),
80 HPV prototypes are now published, since HPV 46 is
vacant and HPVs 78 and 79 were not yet published. For
a better identification of heterogeneous HPVs, we di-
vided 80 HPVs into genital and skin HPVs. Although
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146 MATSUKURA AND SUGASEalmost all HPVs were precisely classified into super-
groups by the L1 phylogenetic tree and supergroup As
were labeled as genital HPV (Chan et al., 1995), we
selected 40 HPVs in supergroup A, except for groups A2
and A4, and HPVs 54 and 71 as genital HPV and the
remaining 38 HPVs as skin HPV. In Table 3, 42 genital
HPVs were arranged according to the GC content of the
genome. In addition, we analyzed the similarities of
amino acid sequences of the E6 and the L1 ORF be-
tween each HPV and HPV 16 (see Discussion).
Detection and identification of HPV types
For detection and typing of HPV DNA in unfixed biopsy
specimens of CIN, we modified the blot hybridization
method previously published (Matsukura and Sugase,
1995) as follows. Biopsy tissue (20–500 mg) in the tube
was incubated in 500–1000 ml of lysing buffer (50 mM
Tris–HCl (pH 8.0), 2% sodium dodecyl sulfate (SDS), and
50 mM EDTA) and 100 mg/ml proteinase K at 37°C for 6
to 16 h with rotation. It was sequentially extracted three
times for 3 min each, with an equal volume of water-
saturated phenol, with phenol:chloroform:isoamyl alchol
(25:24:1), and with chloroform:isoamyl alchol (24:1). To
the last aqueous phase, 1/10 vol 3 M Na acetate (pH 5.2)
and 2 vol ethanol were added. DNA was recovered by
centrifugation and dissolved in H2O at 1 mg/ml. Total
NA was digested with PstI, BanI, or MspI in a 20-ml
reaction, and the cleaved product, with 2 ml of loading
uffer (0.2% bromophenol blue, 0.2% xylene cyanol FF,
nd 60% (w/v) sucrose), was electrophoresed on a 1%
garose gel (11 3 14 3 0.65 cm with 0.25–0.35 3 0.3 3
.5-cm slots) using 40 mM Tris acetate, 2 mM EDTA (pH
.0) as running buffer. For better electrophoretic separa-
ion of DNA, a gel was run until the xylene cyanol FF and
romophenol blue migrated at 4.5 and 11 cm, respec-
ively, with circulation of running buffer (30 V for 13 h).
fter electrophoresis, the gel was stained with ethidium
romide and photographed. It was hydrolyzed for 10 min
n 200 ml of 0.2 M HCl and rinsed in deionized water.
ubsequently, it was denatured twice for 15 min, each
ime in 200 ml of 1.5 M NaCl, 0.5 M NaOH with agitation,
nd neutralized in 200 ml of 3.0 M NaCl, 0.5 M Tris–HCl
pH 7.5) in the same manner. DNA in the gel was trans-
erred to a nitrocellulose filter (BA 79, Schleicher and
chuell, Dassel, Germany) under vacuum at 50 mbar for
.5 h using 203 SSC (13 SSC is 0.15 M NaCl, 0.015 M
odium citrate) as transfer buffer and was linked to the
ilter by UV irradiation at 500 mJ/cm2. The filter was
placed in a heat-sealable plastic bag and incubated with
8 ml of hybridization buffer for 6 to 18 h in a 42°C water
bath with shaking. After that, the filter was transferred to
a new bag with a new 8 ml of hybridization buffer and a
heat-denatured HPV probe and incubated for 12 to 18 h
in the bath. Subsequently, the filter was removed from
hybridization solution and washed three times for 10 mineach with 200 ml of washing buffer. The hybridization
and washing were done at Tm 240°C, using appropriate
buffer conditions for the HPV DNA probe (see GC content
in Table 3). For example, the hybridization buffer for the
HPV 58 probe consisted of 20% formamide, 53 SSC, 50
mM Hepes buffer (pH 7.0), 0.02% each of polyvinylpyro-
lidone, Ficoll, and bovine albumin fraction V, and the
washing was done with 1.63 SSC, 0.1% SDS at 48°C. In
preparing the probe, DNA fragments of an entire HPV
genome were labeled with [a-32P]dCTP using random
ligonucleotide primers to spec. act. 1 3 109 cpm/mg and
a 1.0 3 107-cpm probe was used for one filter. Finally, the
filter was exposed to X-ray films (XAR-5 or BioMax, East-
man Kodak, Rochester, NY) with intensifying screens at
280°C for 3 h to 3 days, and the films were developed.
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